AAAAAA
Results:
1-11
|
Results: 11
Authors:
Bianco, FJ
Wood, DP
de Oliveira, JG
Nemeth, JA
Beaman, AA
Cher, ML
Citation: Fj. Bianco et al., Proliferation of prostate cancer cells in the bone marrow predicts recurrence in patients with localized prostate cancer, PROSTATE, 49(4), 2001, pp. 235-242
Authors:
Dong, Z
Nemeth, JA
Cher, ML
Palmer, KC
Bright, RC
Fridman, R
Citation: Z. Dong et al., Differential regulation of matrix metalloproteinase-9, tissue inhibitor ofmetalloproteinase-1 (TIMP-1) and TIMP-2 expression in co-cultures of prostate cancer and stromal cells, INT J CANC, 93(4), 2001, pp. 507-515
Authors:
Nemeth, JA
Roberts, JW
Mullins, CM
Cher, ML
Citation: Ja. Nemeth et al., Persistence of human vascular endothelium in experimental human prostate cancer bone tumors, CLIN EXP M, 18(3), 2000, pp. 231-237
Authors:
Hukku, B
Mally, M
Cher, ML
Peehl, DM
Kung, HF
Rhim, JS
Citation: B. Hukku et al., Stepwise genetic changes associated with progression of nontumorigenic HPV-18 immortalized human prostate cancer-derived cell line to a malignant phenotype, CANC GENET, 120(2), 2000, pp. 117-126
Authors:
Toth, M
Bernardo, MM
Gervasi, DC
Soloway, PD
Wang, ZP
Bigg, HF
Overall, CM
DeClerck, YA
Tschesche, H
Cher, ML
Brown, S
Mobashery, S
Fridman, R
Citation: M. Toth et al., Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (membrane type 1)-MMP-dependent activation of pro-MMP-2, J BIOL CHEM, 275(52), 2000, pp. 41415-41423
Authors:
Cher, ML
de Oliveira, JG
Beaman, AA
Nemeth, JA
Hussain, M
Wood, DP
Citation: Ml. Cher et al., Cellular proliferation and prevalence of micrometastatic cells in the bonemarrow of patients with clinically localized prostate cancer, CLIN CANC R, 5(9), 1999, pp. 2421-2425
Authors:
Upadhyay, J
Shekarriz, B
Nemeth, JA
Dong, Z
Cummings, GD
Fridman, R
Sakr, W
Grignon, DJ
Cher, ML
Citation: J. Upadhyay et al., Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: Change in cellular localization associated with high-grade prostatic intraepithelial neoplasia, CLIN CANC R, 5(12), 1999, pp. 4105-4110
Authors:
Hillman, GG
Triest, J
Cher, ML
Kocheril, SV
Talati, BR
Citation: Gg. Hillman et al., Prospects of immunotherapy for the treatment of prostate carcinoma - A review, CANCER DET, 23(4), 1999, pp. 333-342
Authors:
Virgin, JB
Hurley, PM
Nahhas, FA
Bebchuk, KG
Mohamed, AN
Sakr, WA
Bright, RK
Cher, ML
Citation: Jb. Virgin et al., Isochromosome 8q formation is associated with 8p loss of heterozygosity ina prostate cancer cell line, PROSTATE, 41(1), 1999, pp. 49-57
Authors:
Kattar, MM
Grignon, DJ
Eble, JN
Hurley, PM
Lewis, PE
Sakr, WE
Cher, ML
Citation: Mm. Kattar et al., Chromosomal analysis of renal angiomyolipoma by comparative genomic hybridization: Evidence for clonal origin, HUMAN PATH, 30(3), 1999, pp. 295-299
Authors:
Nemeth, JA
Harb, JF
Barroso, U
He, ZQ
Grignon, DJ
Cher, ML
Citation: Ja. Nemeth et al., Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone, CANCER RES, 59(8), 1999, pp. 1987-1993
Risultati:
1-11
|